 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | lactobacillus reuteri (BGP014) / BioGaia
Trial completion date, Trial primary completion date: A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis (clinicaltrials.gov) - Feb 14, 2023
P1/2, N=50, Recruiting, Sponsor: BioGaia Pharma AB
Trial completion date: Dec 2022 --> Dec 2023 | Trial primary completion date: Dec 2022 --> Dec 2023
- | lactobacillus reuteri (BGP014) / BioGaia
Trial initiation date: A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis (clinicaltrials.gov) - Feb 10, 2022
P1/2, N=50, Recruiting, Sponsor: BioGaia Pharma AB
Trial completion date: Dec 2022 --> Dec 2023 | Trial primary completion date: Dec 2022 --> Dec 2023 Initiation date: Nov 2021 --> Feb 2022
- | lactobacillus reuteri (BGP014) / BioGaia
New P1/2 trial: A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis (clinicaltrials.gov) - Nov 11, 2021
P1/2, N=50, Recruiting, Sponsor: BioGaia Pharma AB